Research Site

Hobart 7000

1 studies enrolling now · 8 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, B-cell Non Hodgkin Lymphoma, Breast Cancer, Carcinoma, Non-Small Cell Lung, Chronic Lymphocytic Leukemia, Colorectal Cancer, Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, High-grade B-cell Lymphoma, Metastatic Clear Cell Renal Cell Carcinoma, Polycythemia Vera

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL — Running, not enrolling
• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling
• A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) — Running, not enrolling
• A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma — Running, not enrolling
• Study to Assess SLN124 in Patients With Polycythemia Vera — Running, not enrolling
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX — Completed